Investor optimism is rising on hopes of a US-Iran agreement, potentially easing energy market concerns and geopolitical uncertainty. Helios...

India's economy is experiencing a slowdown. High growth and low inflation mask underlying issues of weak demand and poor productivity. This...

Karnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...

India's long-term growth outlook remains robust despite global geopolitical uncertainties and intermittent market volatility, supported by ...

Global markets are cautiously optimistic about a potential US-Iran agreement easing geopolitical risks and crude oil volatility. However, I...

India’s REIT and InvIT market could attract an additional Rs 11.6 trillion in investments by 2030, taking total assets under management bey...

Indian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...

Despite record FII outflows from Indian equities since September 2024, Jefferies said India remains a consensus underweight among emerging ...

Geopolitical shifts and the drive for self-reliance are creating long-term investment opportunities in India's defence and electrification ...

Monarch Networth Capital expects Nifty to reach 27,000-28,000 in 2026, driven by earnings recovery, capex growth and lower interest rates. ...

Suzlon Energy shares rose 3% after management unveiled an ambitious FY31 growth roadmap at its Investor Day. The company plans to evolve fr...

SpaceX's massive IPO is making waves globally. However, Indian market experts believe this will not directly impact upcoming listings of Ji...

Indian artificial intelligence companies are increasingly securing funding from the United States. Investors are drawn to promising returns...

Foreign investors have significantly reduced holdings in many Nifty companies since September 2024. This has impacted top blue-chip stocks,...

India's IPO arena is poised for dynamic growth, with a wave of businesses on the brink of launching their public shares, fueled by an incre...

Citi Research lowered its Nifty target due to rising earnings risks linked to geopolitical tensions and other macro concerns. However, it r...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...